Showing results (41-50 of 263) with videos related to
Sort By:
Pageof 27
Cancer|November 1, 1994
Parametric survival analysis of adjuvant therapy for stage II breast cancerJ W Gamel, R L Vogel, P Valagussa, et al.Cancer Chemotherapy and Pharmacology|January 1, 1978
Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerM De Lena, R Zucali, G Viganotti, et al.British Medical Journal|April 3, 1976
Response and survival in advanced breast cancer after two non-cross-resistant combinationsC Brambilla, M De Lena, A Rossi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Second acute leukemia and other malignancies following treatment for Hodgkin's diseaseP Valagussa, A Santoro, F Fossati-Bellani, et al.The British Journal of Cancer. Supplement|March 1, 1975
Staging laparotomy in non-Hodgkin's lymphomataG Bonadonna, F Pizzetti, R Musumeci, et al.Medical and Pediatric Oncology|January 1, 1977
Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomasS Monfardini, G Tancini, M DeLena, et al.Medical Oncology (Northwood, London, England)|March 14, 2000
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experienceS Viviani, P Notti, V Bonfante, et al.American Journal of Clinical Oncology|August 1, 1988
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancerC Verusio, E Bajetta, L Ferrari, et al.Computers and Biomedical Research, an International Journal|October 1, 1986
BREASTCAN: an expert system for postoperative breast cancer therapyS Gaglio, C Ruggiero, G Spinelli, et al.Cancer Clinical Trials|January 1, 1979
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancerG Tancini, E Bajetta, S Marchini, et al.Pageof 27